Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan
· Delayed Price · Currency is TWD 54.50
+2.10 (4.01%)
Feb 17, 2025, 9:00 AM CST
Orient EuroPharma Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 14, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 4,754 | 3,374 | 3,140 | 3,153 | 4,173 | 4,823 | Upgrade
|
| Market Cap Growth | 18.50% | 7.46% | -0.41% | -24.43% | -13.49% | 6.72% | Upgrade
|
| Enterprise Value | 8,839 | 7,274 | 6,427 | 5,292 | 5,012 | 5,627 | Upgrade
|
| Last Close Price | 54.80 | 38.12 | 35.48 | 34.74 | 44.26 | 49.37 | Upgrade
|
| PE Ratio | 24.92 | 23.44 | - | 26.24 | 20.94 | 19.47 | Upgrade
|
| PS Ratio | 1.06 | 0.73 | 0.66 | 0.66 | 0.78 | 0.79 | Upgrade
|
| PB Ratio | 0.91 | 0.81 | 0.91 | 0.91 | 1.07 | 1.27 | Upgrade
|
| P/TBV Ratio | 0.85 | 0.97 | 1.09 | 1.10 | 1.34 | 1.57 | Upgrade
|
| P/FCF Ratio | - | 156.37 | - | - | 11.10 | 47.11 | Upgrade
|
| P/OCF Ratio | 254.49 | 27.89 | - | 40.61 | 6.86 | 21.21 | Upgrade
|
| EV/Sales Ratio | 1.98 | 1.58 | 1.36 | 1.11 | 0.93 | 0.92 | Upgrade
|
| EV/EBITDA Ratio | 30.29 | 30.85 | 913.23 | 87.72 | 18.01 | 11.62 | Upgrade
|
| EV/EBIT Ratio | 109.43 | 103.01 | - | - | 42.71 | 16.73 | Upgrade
|
| EV/FCF Ratio | -174.36 | 337.06 | - | - | 13.34 | 54.96 | Upgrade
|
| Debt / Equity Ratio | 0.85 | 1.16 | 1.46 | 1.22 | 0.62 | 0.57 | Upgrade
|
| Debt / EBITDA Ratio | 15.68 | 16.88 | 112.21 | 44.25 | 7.65 | 4.18 | Upgrade
|
| Debt / FCF Ratio | - | 224.34 | - | - | 6.40 | 21.18 | Upgrade
|
| Asset Turnover | 0.38 | 0.43 | 0.48 | 0.54 | 0.67 | 0.81 | Upgrade
|
| Inventory Turnover | 1.97 | 1.99 | 2.26 | 2.15 | 2.09 | 2.54 | Upgrade
|
| Quick Ratio | 0.60 | 0.78 | 0.69 | 0.82 | 1.18 | 1.06 | Upgrade
|
| Current Ratio | 0.98 | 1.14 | 1.10 | 1.21 | 1.78 | 1.73 | Upgrade
|
| Return on Equity (ROE) | 5.07% | 4.45% | -8.57% | 2.02% | 2.77% | 3.44% | Upgrade
|
| Return on Assets (ROA) | 0.56% | 0.42% | -0.94% | -0.68% | 0.91% | 2.78% | Upgrade
|
| Return on Capital (ROIC) | 0.65% | 0.51% | -1.16% | -0.86% | 1.19% | 3.64% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.27% | 0.99% | - | - | 2.05% | 6.16% | Upgrade
|
| Earnings Yield | 4.02% | 4.27% | -9.90% | 3.81% | 4.78% | 5.13% | Upgrade
|
| FCF Yield | -1.07% | 0.64% | -27.32% | -47.10% | 9.01% | 2.12% | Upgrade
|
| Dividend Yield | 1.82% | 2.62% | - | 2.45% | 3.39% | 3.65% | Upgrade
|
| Payout Ratio | 45.44% | - | - | 108.28% | 78.35% | 63.05% | Upgrade
|
| Buyback Yield / Dilution | -0.23% | -0.23% | 0.24% | 0.21% | -0.07% | 0.03% | Upgrade
|
| Total Shareholder Return | 1.60% | 2.39% | 0.24% | 2.66% | 3.32% | 3.67% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.